AN INTACT CYSTEINE-RICH DOMAIN IS REQUIRED FOR DYSTROPHIN FUNCTION

被引:62
作者
BIES, RD
CASKEY, CT
FENWICK, R
机构
[1] BAYLOR COLL MED,DIV CARDIOL,HOUSTON,TX 77030
[2] BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030
关键词
DUCHENNE; BECKER; DELETION; LYMPHOCYTE PCR; SPLICING;
D O I
10.1172/JCI115909
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The carboxyl terminus of dystrophin is encoded by a highly conserved, alternatively spliced region of the gene. The few rare mutations reported in this region are of interest in unraveling the function of the dystrophin molecule. An unusual case of infantile onset Duchenne muscular dystrophy (DMD) with an internal 3' genomic deletion, and a membrane localized non-functional dystrophin protein, was used to explore the functional activity of this region. The patient's cDNA sequence showed an intragenic 1824-bp deletion precisely excising the cysteine rich and alternatively spliced COOH-terminal domains of dystrophin. The unaltered final 2.7 kb of the patients transcript was defined as a single exon localized to two genomic fragments, with the 5.9 kb HindIII fragment containing the stop codon. To understand the significance of deletions in this important region of the dystrophin gene, we mapped the order and cDNA coordinates for the 3' genomic HindIII fragments encoding the cysteine rich and alternative splicing domains. This 3' gene map was used to compare the clinical phenotype of the other reported COOH-terminal deletions in the literature. Our analysis concludes that the cysteine-rich domain confers an important function for the dystrophin protein.
引用
收藏
页码:666 / 672
页数:7
相关论文
共 37 条
[1]
HUMAN DYSTROPHIN EXPRESSION IN MDX MICE AFTER INTRAMUSCULAR INJECTION OF DNA CONSTRUCTS [J].
ACSADI, G ;
DICKSON, G ;
LOVE, DR ;
JANI, A ;
WALSH, FS ;
GURUSINGHE, A ;
WOLFF, JA ;
DAVIES, KE .
NATURE, 1991, 352 (6338) :815-818
[2]
ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856
[3]
PRESERVATION OF THE C-TERMINUS OF DYSTROPHIN MOLECULE IN THE SKELETAL-MUSCLE FROM BECKER MUSCULAR-DYSTROPHY [J].
ARAHATA, K ;
BEGGS, AH ;
HONDA, H ;
ITO, S ;
ISHIURA, S ;
TSUKAHARA, T ;
ISHIGURO, T ;
EGUCHI, C ;
ORIMO, S ;
ARIKAWA, E ;
KAIDO, M ;
NONAKA, I ;
SUGITA, H ;
KUNKEL, LM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 101 (02) :148-156
[4]
IMMUNOSTAINING OF SKELETAL AND CARDIAC-MUSCLE SURFACE-MEMBRANE WITH ANTIBODY AGAINST DUCHENNE MUSCULAR-DYSTROPHY PEPTIDE [J].
ARAHATA, K ;
ISHIURA, S ;
ISHIGURO, T ;
TSUKAHARA, T ;
SUHARA, Y ;
EGUCHI, C ;
ISHIHARA, T ;
NONAKA, I ;
OZAWA, E ;
SUGITA, H .
NATURE, 1988, 333 (6176) :861-863
[5]
BARON MD, 1987, J BIOL CHEM, V262, P17623
[6]
MOLECULAR AND CLINICAL CORRELATIONS OF DELETIONS LEADING TO DUCHENNE AND BECKER MUSCULAR-DYSTROPHIES [J].
BAUMBACH, LL ;
CHAMBERLAIN, JS ;
WARD, PA ;
FARWELL, NJ ;
CASKEY, CT .
NEUROLOGY, 1989, 39 (04) :465-474
[7]
HUMAN AND MURINE DYSTROPHIN MESSENGER-RNA TRANSCRIPTS ARE DIFFERENTIALLY EXPRESSED DURING SKELETAL-MUSCLE, HEART, AND BRAIN-DEVELOPMENT [J].
BIES, RD ;
PHELPS, SF ;
CORTEZ, MD ;
ROBERTS, R ;
CASKEY, CT ;
CHAMBERLAIN, JS .
NUCLEIC ACIDS RESEARCH, 1992, 20 (07) :1725-1731
[8]
EXPRESSION AND LOCALIZATION OF DYSTROPHIN IN HUMAN CARDIAC PURKINJE-FIBERS [J].
BIES, RD ;
FRIEDMAN, D ;
ROBERTS, R ;
PERRYMAN, MB ;
CASKEY, CT .
CIRCULATION, 1992, 86 (01) :147-153
[9]
DUCHENNE MUSCULAR-DYSTROPHY - DEFICIENCY OF DYSTROPHIN AT THE MUSCLE-CELL SURFACE [J].
BONILLA, E ;
SAMITT, CE ;
MIRANDA, AF ;
HAYS, AP ;
SALVIATI, G ;
DIMAURO, S ;
KUNKEL, LM ;
HOFFMAN, EP ;
ROWLAND, LP .
CELL, 1988, 54 (04) :447-452
[10]
SEQUENCE SIMILARITY OF THE AMINO-TERMINAL DOMAIN OF DROSOPHILA BETA-SPECTRIN TO ALPHA-ACTININ AND DYSTROPHIN [J].
BYERS, TJ ;
HUSAINCHISHTI, A ;
DUBREUIL, RR ;
BRANTON, D ;
GOLDSTEIN, LSB .
JOURNAL OF CELL BIOLOGY, 1989, 109 (04) :1633-1641